406 related articles for article (PubMed ID: 31936740)
1. Polymeric Nanoparticles for the Treatment of Malignant Gliomas.
Mahmoud BS; AlAmri AH; McConville C
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936740
[TBL] [Abstract][Full Text] [Related]
2. Overcoming the Blood-Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours.
Ferraris C; Cavalli R; Panciani PP; Battaglia L
Int J Nanomedicine; 2020; 15():2999-3022. PubMed ID: 32431498
[TBL] [Abstract][Full Text] [Related]
3. Targeted brain delivery nanoparticles for malignant gliomas.
Pinto MP; Arce M; Yameen B; Vilos C
Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
[TBL] [Abstract][Full Text] [Related]
4. Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption.
Janowicz PW; Houston ZH; Bunt J; Fletcher NL; Bell CA; Cowin G; Howard CB; Taslima D; Westra van Holthe N; Prior A; Soh V; Ghosh S; Humphries J; Huda P; Mahler SM; Richards LJ; Thurecht KJ
Biomaterials; 2022 Apr; 283():121416. PubMed ID: 35217483
[TBL] [Abstract][Full Text] [Related]
5. Drug delivery strategies for the treatment of malignant gliomas.
Allhenn D; Boushehri MA; Lamprecht A
Int J Pharm; 2012 Oct; 436(1-2):299-310. PubMed ID: 22721856
[TBL] [Abstract][Full Text] [Related]
6. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
[TBL] [Abstract][Full Text] [Related]
7. Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: An overview.
Song YH; De R; Lee KT
Adv Colloid Interface Sci; 2023 Oct; 320():103008. PubMed ID: 37776736
[TBL] [Abstract][Full Text] [Related]
8. Nanobiotechnology-based drug delivery in brain targeting.
Dinda SC; Pattnaik G
Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
[TBL] [Abstract][Full Text] [Related]
9. Functionalized nanoparticles crossing the brain-blood barrier to target glioma cells.
Wu Y; Qian Y; Peng W; Qi X
PeerJ; 2023; 11():e15571. PubMed ID: 37426416
[TBL] [Abstract][Full Text] [Related]
10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
11. Polymeric nanoparticles for drug delivery in glioblastoma: State of the art and future perspectives.
Madani F; Esnaashari SS; Webster TJ; Khosravani M; Adabi M
J Control Release; 2022 Sep; 349():649-661. PubMed ID: 35878729
[TBL] [Abstract][Full Text] [Related]
12. Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.
Zhang W; Mehta A; Tong Z; Esser L; Voelcker NH
Adv Sci (Weinh); 2021 May; 8(10):2003937. PubMed ID: 34026447
[TBL] [Abstract][Full Text] [Related]
13. The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery.
Zhan C; Lu W
Curr Pharm Biotechnol; 2012 Sep; 13(12):2380-7. PubMed ID: 23016643
[TBL] [Abstract][Full Text] [Related]
14. Local strategies and delivery systems for the treatment of malignant gliomas.
Yu F; Asghar S; Zhang M; Zhang J; Ping Q; Xiao Y
J Drug Target; 2019 Apr; 27(4):367-378. PubMed ID: 30101621
[TBL] [Abstract][Full Text] [Related]
15. Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas.
Huang X; Shi S; Wang H; Zhao T; Wang Y; Huang S; Su Y; Zhao C; Yang M
Int Immunopharmacol; 2023 Apr; 117():109990. PubMed ID: 37012874
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors.
Reddy S; Tatiparti K; Sau S; Iyer AK
Drug Discov Today; 2021 Aug; 26(8):1944-1952. PubMed ID: 33865978
[TBL] [Abstract][Full Text] [Related]
17. Recent Approaches and Success of Liposome-Based Nano Drug Carriers for the Treatment of Brain Tumor.
Shaw TK; Paul P
Curr Drug Deliv; 2022; 19(8):815-829. PubMed ID: 34961462
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of Nanomedicine in Management of Alzheimer's Disease and Glioma.
Anwar F; Al-Abbasi FA; Naqvi S; Sheikh RA; Alhayyani S; Asseri AH; Asar TO; Kumar V
Int J Nanomedicine; 2023; 18():2737-2756. PubMed ID: 37250469
[TBL] [Abstract][Full Text] [Related]
19. Polymeric magnetic nanoparticles: a multitargeting approach for brain tumour therapy and imaging.
Joshi B; Joshi A
Drug Deliv Transl Res; 2022 Jul; 12(7):1588-1604. PubMed ID: 34537930
[TBL] [Abstract][Full Text] [Related]
20. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
